Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/1998 - 12/2000

Data type

Scientific literature

Keywords

Alzheimer's disease and other dementias

Citation

Authors

Migliaccio-Walle K, Getsios D, Caro JJ, Ishak KJ, O'Brien JA, Papadopoulos G, AHEAD Study Group

Journal

Clin Ther

Volume

Issue

Pages

1806-25

Publication year

2003

Suggested citation

Migliaccio-Walle K, Getsios D, Caro JJ, Ishak KJ, O'Brien JA, Papadopoulos G, AHEAD Study Group. Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States. Clin Ther. 2003; 25(6): 1806-25.

DOI

10.1016/s0149-2918(03)80171-6

PMID

12860500

GHDx Entry last modified on: Dec 12, 2023

Header sites

Search form

Main menu

Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States

Nav